Institutions / Affinity Asset Advisors, LLC / Holdings

Affinity Asset Advisors, LLC

All holdings · as of Dec 31, 2025

Company	Class	Value	Shares	% of portfolio
ROCKET PHARMACEUTICALS INC	—	$1.8K	75,000	0.0%
Adagio Medical Holdings, Inc.	—	$83.2K	80,000	0.0%
Q32 Bio Inc.	—	$92.2K	27,777	0.0%
X4 Pharmaceuticals, Inc	—	$580.0K	145,000	0.0%
Perceptive Capital Solutions Corp	—	$651.5K	50,000	0.0%
MacroGenics, Inc.	—	$779.7K	484,308	0.1%
Perspective Therapeutics, Inc.	—	$825.0K	300,000	0.1%
COGENT BIOSCIENCES INC	—	$1.18M	1,000,000	0.1%
UNIQURE NV	—	$1.20M	50,000	0.1%
COMPASS Pathways plcCMPS	ADR	$1.38M	200,000	0.1%
KEZAR LIFE SCIENCES INC	—	$1.44M	229,076	0.1%
Ultragenyx Pharmaceutical Inc.	—	$1.73M	75,000	0.1%
GERON CORP	—	$1.98M	1,500,000	0.1%
EUPRAXIA PHARMACEUTICALS INC.	—	$2.27M	300,000	0.2%
Orchestra BioMed Holdings, Inc.OBIO	Common Stock	$2.38M	572,804	0.2%
Anteris Technologies Global Corp.	—	$2.43M	486,684	0.2%
OAKTREE ACQUISITION CORP III	—	$2.65M	250,000	0.2%
MERSANA THERAPEUTICS INC	—	$2.89M	100,000	0.2%
ARRIVENT BIOPHARMA INCAVBP	Common Stock	$3.02M	150,000	0.2%
BELITE BIO, INCBLTE	ADR	$3.20M	20,000	0.2%
AMGEN INC	—	$3.27M	10,000	0.2%
Crinetics Pharmaceuticals, Inc.	—	$3.49M	75,000	0.3%
NextCure, Inc.NXTC	Common Stock	$3.51M	247,294	0.3%
iBio, Inc.IBIO	Common Stock	$3.97M	2,057,200	0.3%
ARROWHEAD PHARMACEUTICALS, INC.	—	$4.65M	70,000	0.3%
Dianthus Therapeutics, Inc.	—	$4.74M	115,000	0.3%
PROQR THRAPEUTICS N V	—	$4.96M	2,454,278	0.4%
Immunovant, Inc.IMVT	Common Stock	$5.08M	200,000	0.4%
Climb Bio, Inc.CLYM	Common Stock	$5.20M	1,300,000	0.4%
AVADEL PHARMACEUTICALS PLC	—	$5.39M	250,000	0.4%
Rezolute, Inc.	—	$5.55M	2,351,144	0.4%
NEWAMSTERDAM PHARMA COMPANY	—	$5.63M	245,000	0.4%
enGene Therapeutics Inc.	—	$5.81M	643,370	0.4%
Verrica Pharmaceuticals Inc.VRCA	Common Stock	$5.88M	707,338	0.4%
ASCENDIS PHARMA A/S	—	$6.40M	30,000	0.5%
CELCUITY INC	—	$6.52M	3,000,000	0.5%
Karyopharm Therapeutics Inc.	—	$6.55M	889,575	0.5%
Sagimet Biosciences Inc.SGMT	Common Stock	$6.80M	1,148,245	0.5%
Arcus Biosciences, Inc.	—	$7.15M	300,000	0.5%
Viridian Therapeutics, Inc.	—	$7.78M	250,000	0.6%
MBX Biosciences, Inc.MBX	Common Stock	$7.88M	250,000	0.6%
Revolution Medicines, Inc.	—	$7.96M	100,000	0.6%
Sutro Biopharma, Inc.	—	$8.66M	748,382	0.6%
Tango Therapeutics, Inc.	—	$8.86M	1,000,000	0.6%
Zura Bio Limited	—	$9.50M	1,813,671	0.7%
Celldex Therapeutics, Inc.	—	$9.51M	350,000	0.7%
NEWAMSTERDAM PHARMA COMPANY	—	$9.65M	275,000	0.7%
TRAVERE THERAPEUTICS INC	—	$9.99M	7,000,000	0.7%
JADE BIOSCIENCES, INC.	—	$11.03M	714,956	0.8%
Travere Therapeutics, Inc.	—	$11.46M	300,000	0.8%